Compliance, Quality Issues Cast Shadow on Pharma Deals

Global drugmakers may have turned risk-averse toward buying or forming partnerships with Indian makers of generic medicines after being hit by revenue losses stemming from quality and compliance issues over previous acquisitions and tie-ups.
LiveMint